Company Filing History:
Years Active: 2001
Title: May S. Sutherland: Innovator in Estrogen Receptor Modulation
Introduction
May S. Sutherland is a notable inventor based in Bothell, WA (US). She has made significant contributions to the field of pharmaceutical sciences, particularly in the modulation of estrogen receptors. Her work has implications for various therapeutic applications, showcasing her innovative spirit and dedication to advancing medical research.
Latest Patents
May S. Sutherland holds 1 patent for her invention titled "Compounds and methods for modulation of estrogen receptors." This patent discloses compounds that modulate gene expression through the estrogen receptor (ER), along with pharmaceutical compositions containing these compounds. Her research is pivotal in understanding how these compounds can influence gene expression and potentially lead to new treatments.
Career Highlights
Throughout her career, May has been associated with Signal Pharmaceuticals, Inc., where she has contributed her expertise in pharmaceutical development. Her work at the company has allowed her to collaborate with other talented professionals in the field, further enhancing her impact on medical research.
Collaborations
May has worked alongside esteemed colleagues such as Bernd M. Stein and David Wesley Anderson. These collaborations have fostered a productive environment for innovation and have led to advancements in their shared research interests.
Conclusion
May S. Sutherland exemplifies the role of an innovative inventor in the pharmaceutical industry. Her contributions to estrogen receptor modulation highlight her commitment to advancing medical science and improving therapeutic options.